Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
50 /100
MEDIUM RISK
Score updated Oct 13, 2026

LBRX — LB Pharmaceuticals Inc Dilution Risk Tracker

Track LBRX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track LBRX — Get alerts when the score changes →

As of October 13, 2026, LB Pharmaceuticals Inc (LBRX) has a DilutionWatch DilutionScore of 50/100, rated MEDIUM dilution risk. LB Pharmaceuticals Inc has a market capitalization of $1.16B, 32.26M shares outstanding, 77 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $100.00M, 116.9K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
62
💰 Cash Runway
10
📊 Float Risk
55
⚠️ Warrant Exposure
15
🔄 Convertible Debt
40

Dilution Forecast

⛅
Watch
Minor dilution signals detected
model est. 10%
💰 Capital Raise model 20%
• Active shelf registration ($100M, 9% of market cap)
🔔 Track LBRX — Get forecast alerts →

Market Data

Market Cap$1.16B
Shares Outstanding32.26M
Float18.10M
Cash$327.79M
Debt$3.47M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore50/100DilutionWatch score record
Shares Outstanding32.26MVerified float table or market cache
Public Float18.10MVerified float table or market cache
Market Cap$1.16BMarket data cache
Cash Runway32.3 monthsDilutionWatch score inputs
Shelf Capacity$100.00MSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants116.9KSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 3 1, 4 1, 424B3 1, EFFECT 1, S-1 1, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 22.1% shares (2026Q1 vs prior)
77 institutional holders · 30.39M shares
#1 Deep Track Capital, LP 3.35M shares
#2 BlackRock, Inc. 2.47M shares
#3 RA CAPITAL MANAGEMENT, L.P. 2.21M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest6.01M
Days to Cover14.5
% of Float33.2%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-11
EFFECT EFFECT 2026-04-14
424B3 ATM 2026-04-14
S-1 SHELF 2026-04-06
4 INSIDER TRANSACTION 2026-03-10
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual LBRX Dilution Snapshot

LB Pharmaceuticals Inc (LBRX) has a DilutionScore of 50/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

LBRX's DilutionScore is currently 50/100 (Medium risk), with 4 score changes tracked over 89 days. The score improved from 47/100 (Medium risk).

Period Score Risk Level Duration
Oct 13, 202650/100MEDIUM1 day
Sep 28 – Oct 12, 202647/100MEDIUM15 days
Aug 22 – Sep 27, 202650/100MEDIUM37 days
Aug 14 – Aug 21, 202644/100MEDIUM7 days
Jul 16 – Aug 13, 202648/100MEDIUM29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

LBRX shares outstanding have increased 0.0% from 28.67M (Mar 2026) to 28.68M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 24, 202628.68M18.10M▲ 11.31%
May 23, 202628.68M16.26M▼ 10.16%
May 18, 202628.68M18.10M▼ 7.81%
May 04, 202628.68M19.63M▼ 0.41%
Apr 20, 202628.67M19.71M▲ 28.55%
Mar 28, 202628.67M15.33M▲ 13.34%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track LBRX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment LBRX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking LBRX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for LBRX
LBRX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.